nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—SLC22A5—ulcerative colitis	0.224	0.791	CbGaD
Lidocaine—osteoarthritis—Methylprednisolone—ulcerative colitis	0.166	0.5	CpDpCtD
Lidocaine—osteoarthritis—Prednisone—ulcerative colitis	0.166	0.5	CpDpCtD
Lidocaine—ABCB1—ulcerative colitis	0.0592	0.209	CbGaD
Lidocaine—SLC22A5—Nicotine—ulcerative colitis	0.027	0.0968	CbGbCtD
Lidocaine—CYP2A6—Nicotine—ulcerative colitis	0.0205	0.0736	CbGbCtD
Lidocaine—CYP2A6—Prednisolone—ulcerative colitis	0.0135	0.0484	CbGbCtD
Lidocaine—CYP2B6—Nicotine—ulcerative colitis	0.0134	0.0479	CbGbCtD
Lidocaine—CYP2B6—Cholecalciferol—ulcerative colitis	0.012	0.043	CbGbCtD
Lidocaine—CYP2C8—Nicotine—ulcerative colitis	0.0101	0.0363	CbGbCtD
Lidocaine—CYP3A4—Budesonide—ulcerative colitis	0.00943	0.0338	CbGbCtD
Lidocaine—CYP2C8—Cholecalciferol—ulcerative colitis	0.00908	0.0325	CbGbCtD
Lidocaine—CYP3A7—Hydrocortisone—ulcerative colitis	0.00876	0.0314	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.00876	0.0314	CbGbCtD
Lidocaine—CYP3A5—Sulfasalazine—ulcerative colitis	0.00819	0.0293	CbGbCtD
Lidocaine—CYP2A6—Dexamethasone—ulcerative colitis	0.00797	0.0286	CbGbCtD
Lidocaine—CYP1A2—Nicotine—ulcerative colitis	0.00783	0.0281	CbGbCtD
Lidocaine—CYP2C9—Nicotine—ulcerative colitis	0.00706	0.0253	CbGbCtD
Lidocaine—ABCB1—Methylprednisolone—ulcerative colitis	0.00703	0.0252	CbGbCtD
Lidocaine—CYP3A5—Hydrocortisone—ulcerative colitis	0.00657	0.0235	CbGbCtD
Lidocaine—CYP2D6—Nicotine—ulcerative colitis	0.00645	0.0231	CbGbCtD
Lidocaine—CYP2C9—Cholecalciferol—ulcerative colitis	0.00633	0.0227	CbGbCtD
Lidocaine—CYP2C8—Hydrocortisone—ulcerative colitis	0.00632	0.0226	CbGbCtD
Lidocaine—CYP2D6—Cholecalciferol—ulcerative colitis	0.00579	0.0208	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.00545	0.0195	CbGbCtD
Lidocaine—CYP3A7—Dexamethasone—ulcerative colitis	0.00545	0.0195	CbGbCtD
Lidocaine—CYP2B6—Dexamethasone—ulcerative colitis	0.00519	0.0186	CbGbCtD
Lidocaine—ABCB1—Betamethasone—ulcerative colitis	0.00457	0.0164	CbGbCtD
Lidocaine—ABCB1—Prednisolone—ulcerative colitis	0.00451	0.0162	CbGbCtD
Lidocaine—ABCB1—Hydrocortisone—ulcerative colitis	0.00428	0.0153	CbGbCtD
Lidocaine—ABCB1—Prednisone—ulcerative colitis	0.00426	0.0153	CbGbCtD
Lidocaine—CYP3A4—Methylprednisolone—ulcerative colitis	0.00421	0.0151	CbGbCtD
Lidocaine—CYP3A4—Nicotine—ulcerative colitis	0.0041	0.0147	CbGbCtD
Lidocaine—CYP3A5—Dexamethasone—ulcerative colitis	0.00408	0.0146	CbGbCtD
Lidocaine—CYP2C8—Dexamethasone—ulcerative colitis	0.00393	0.0141	CbGbCtD
Lidocaine—CYP3A4—Cholecalciferol—ulcerative colitis	0.00368	0.0132	CbGbCtD
Lidocaine—CYP3A4—Triamcinolone—ulcerative colitis	0.00319	0.0114	CbGbCtD
Lidocaine—CYP2C9—Dexamethasone—ulcerative colitis	0.00274	0.00982	CbGbCtD
Lidocaine—CYP3A4—Betamethasone—ulcerative colitis	0.00274	0.00982	CbGbCtD
Lidocaine—CYP3A4—Prednisolone—ulcerative colitis	0.0027	0.00969	CbGbCtD
Lidocaine—ABCB1—Dexamethasone—ulcerative colitis	0.00266	0.00953	CbGbCtD
Lidocaine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00256	0.00918	CbGbCtD
Lidocaine—CYP3A4—Prednisone—ulcerative colitis	0.00255	0.00915	CbGbCtD
Lidocaine—CYP2D6—Dexamethasone—ulcerative colitis	0.00251	0.00898	CbGbCtD
Lidocaine—CYP3A4—Dexamethasone—ulcerative colitis	0.00159	0.00571	CbGbCtD
Lidocaine—Procainamide—SLC22A4—ulcerative colitis	0.000497	0.479	CrCbGaD
Lidocaine—Procainamide—SLC22A5—ulcerative colitis	0.000373	0.36	CrCbGaD
Lidocaine—Tocainide—ALB—ulcerative colitis	0.000168	0.161	CrCbGaD
Lidocaine—Hypotension—Azathioprine—ulcerative colitis	8.8e-05	0.00111	CcSEcCtD
Lidocaine—Haemorrhage—Prednisolone—ulcerative colitis	8.79e-05	0.00111	CcSEcCtD
Lidocaine—Cardiac arrest—Prednisone—ulcerative colitis	8.78e-05	0.00111	CcSEcCtD
Lidocaine—Bradycardia—Hydrocortisone—ulcerative colitis	8.74e-05	0.0011	CcSEcCtD
Lidocaine—Feeling abnormal—Budesonide—ulcerative colitis	8.69e-05	0.0011	CcSEcCtD
Lidocaine—Confusional state—Mesalazine—ulcerative colitis	8.65e-05	0.00109	CcSEcCtD
Lidocaine—Haemoglobin—Hydrocortisone—ulcerative colitis	8.63e-05	0.00109	CcSEcCtD
Lidocaine—Haemorrhage—Hydrocortisone—ulcerative colitis	8.59e-05	0.00108	CcSEcCtD
Lidocaine—Oedema—Mesalazine—ulcerative colitis	8.58e-05	0.00108	CcSEcCtD
Lidocaine—Anaphylactic shock—Mesalazine—ulcerative colitis	8.58e-05	0.00108	CcSEcCtD
Lidocaine—Visual impairment—Prednisolone—ulcerative colitis	8.47e-05	0.00107	CcSEcCtD
Lidocaine—Shock—Mesalazine—ulcerative colitis	8.44e-05	0.00106	CcSEcCtD
Lidocaine—Nervous system disorder—Mesalazine—ulcerative colitis	8.41e-05	0.00106	CcSEcCtD
Lidocaine—Urticaria—Budesonide—ulcerative colitis	8.38e-05	0.00106	CcSEcCtD
Lidocaine—Hyperhidrosis—Mesalazine—ulcerative colitis	8.29e-05	0.00105	CcSEcCtD
Lidocaine—Bradycardia—Triamcinolone—ulcerative colitis	8.23e-05	0.00104	CcSEcCtD
Lidocaine—Bradycardia—Methylprednisolone—ulcerative colitis	8.21e-05	0.00104	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	8.13e-05	0.00103	CcSEcCtD
Lidocaine—Haemoglobin—Triamcinolone—ulcerative colitis	8.13e-05	0.00102	CcSEcCtD
Lidocaine—Haemoglobin—Methylprednisolone—ulcerative colitis	8.11e-05	0.00102	CcSEcCtD
Lidocaine—Rhinitis—Triamcinolone—ulcerative colitis	8.1e-05	0.00102	CcSEcCtD
Lidocaine—Rhinitis—Methylprednisolone—ulcerative colitis	8.09e-05	0.00102	CcSEcCtD
Lidocaine—Haemorrhage—Triamcinolone—ulcerative colitis	8.08e-05	0.00102	CcSEcCtD
Lidocaine—Haemorrhage—Methylprednisolone—ulcerative colitis	8.07e-05	0.00102	CcSEcCtD
Lidocaine—Eye disorder—Hydrocortisone—ulcerative colitis	8.02e-05	0.00101	CcSEcCtD
Lidocaine—Hypotension—Mesalazine—ulcerative colitis	8.02e-05	0.00101	CcSEcCtD
Lidocaine—Neuropathy peripheral—Dexamethasone—ulcerative colitis	8.01e-05	0.00101	CcSEcCtD
Lidocaine—Neuropathy peripheral—Betamethasone—ulcerative colitis	8.01e-05	0.00101	CcSEcCtD
Lidocaine—Sweating increased—Prednisone—ulcerative colitis	7.77e-05	0.000981	CcSEcCtD
Lidocaine—Visual impairment—Methylprednisolone—ulcerative colitis	7.77e-05	0.00098	CcSEcCtD
Lidocaine—Hypersensitivity—Budesonide—ulcerative colitis	7.77e-05	0.00098	CcSEcCtD
Lidocaine—Feeling abnormal—Azathioprine—ulcerative colitis	7.76e-05	0.000979	CcSEcCtD
Lidocaine—Immune system disorder—Hydrocortisone—ulcerative colitis	7.76e-05	0.000978	CcSEcCtD
Lidocaine—Paraesthesia—Mesalazine—ulcerative colitis	7.7e-05	0.000972	CcSEcCtD
Lidocaine—Erythema—Prednisolone—ulcerative colitis	7.65e-05	0.000965	CcSEcCtD
Lidocaine—Dyspnoea—Mesalazine—ulcerative colitis	7.65e-05	0.000965	CcSEcCtD
Lidocaine—Somnolence—Mesalazine—ulcerative colitis	7.63e-05	0.000962	CcSEcCtD
Lidocaine—Asthenia—Budesonide—ulcerative colitis	7.57e-05	0.000955	CcSEcCtD
Lidocaine—Eye disorder—Methylprednisolone—ulcerative colitis	7.54e-05	0.000951	CcSEcCtD
Lidocaine—Cardiac disorder—Methylprednisolone—ulcerative colitis	7.49e-05	0.000944	CcSEcCtD
Lidocaine—Erythema—Hydrocortisone—ulcerative colitis	7.47e-05	0.000943	CcSEcCtD
Lidocaine—Bradycardia—Dexamethasone—ulcerative colitis	7.47e-05	0.000942	CcSEcCtD
Lidocaine—Bradycardia—Betamethasone—ulcerative colitis	7.47e-05	0.000942	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	7.41e-05	0.000934	CcSEcCtD
Lidocaine—Haemoglobin—Betamethasone—ulcerative colitis	7.37e-05	0.00093	CcSEcCtD
Lidocaine—Haemoglobin—Dexamethasone—ulcerative colitis	7.37e-05	0.00093	CcSEcCtD
Lidocaine—Pain—Mesalazine—ulcerative colitis	7.34e-05	0.000925	CcSEcCtD
Lidocaine—Haemorrhage—Dexamethasone—ulcerative colitis	7.34e-05	0.000925	CcSEcCtD
Lidocaine—Haemorrhage—Betamethasone—ulcerative colitis	7.34e-05	0.000925	CcSEcCtD
Lidocaine—Angiopathy—Methylprednisolone—ulcerative colitis	7.32e-05	0.000923	CcSEcCtD
Lidocaine—Immune system disorder—Methylprednisolone—ulcerative colitis	7.29e-05	0.000919	CcSEcCtD
Lidocaine—Vision blurred—Prednisolone—ulcerative colitis	7.21e-05	0.00091	CcSEcCtD
Lidocaine—Visual impairment—Betamethasone—ulcerative colitis	7.07e-05	0.000892	CcSEcCtD
Lidocaine—Visual impairment—Dexamethasone—ulcerative colitis	7.07e-05	0.000892	CcSEcCtD
Lidocaine—Feeling abnormal—Mesalazine—ulcerative colitis	7.07e-05	0.000892	CcSEcCtD
Lidocaine—Erythema—Triamcinolone—ulcerative colitis	7.04e-05	0.000888	CcSEcCtD
Lidocaine—Erythema—Methylprednisolone—ulcerative colitis	7.02e-05	0.000886	CcSEcCtD
Lidocaine—Angioedema—Prednisolone—ulcerative colitis	6.99e-05	0.000882	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisone—ulcerative colitis	6.98e-05	0.00088	CcSEcCtD
Lidocaine—Dizziness—Budesonide—ulcerative colitis	6.98e-05	0.00088	CcSEcCtD
Lidocaine—Hypersensitivity—Azathioprine—ulcerative colitis	6.94e-05	0.000875	CcSEcCtD
Lidocaine—Dysgeusia—Triamcinolone—ulcerative colitis	6.89e-05	0.000869	CcSEcCtD
Lidocaine—Eye disorder—Dexamethasone—ulcerative colitis	6.86e-05	0.000865	CcSEcCtD
Lidocaine—Eye disorder—Betamethasone—ulcerative colitis	6.86e-05	0.000865	CcSEcCtD
Lidocaine—Angioedema—Hydrocortisone—ulcerative colitis	6.83e-05	0.000861	CcSEcCtD
Lidocaine—Urticaria—Mesalazine—ulcerative colitis	6.81e-05	0.00086	CcSEcCtD
Lidocaine—Back pain—Triamcinolone—ulcerative colitis	6.81e-05	0.000859	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisolone—ulcerative colitis	6.73e-05	0.000848	CcSEcCtD
Lidocaine—Vomiting—Budesonide—ulcerative colitis	6.71e-05	0.000846	CcSEcCtD
Lidocaine—Angiopathy—Betamethasone—ulcerative colitis	6.66e-05	0.000839	CcSEcCtD
Lidocaine—Angiopathy—Dexamethasone—ulcerative colitis	6.66e-05	0.000839	CcSEcCtD
Lidocaine—Rash—Budesonide—ulcerative colitis	6.65e-05	0.000839	CcSEcCtD
Lidocaine—Dermatitis—Budesonide—ulcerative colitis	6.64e-05	0.000838	CcSEcCtD
Lidocaine—Convulsion—Prednisolone—ulcerative colitis	6.63e-05	0.000836	CcSEcCtD
Lidocaine—Headache—Budesonide—ulcerative colitis	6.61e-05	0.000833	CcSEcCtD
Lidocaine—Hypertension—Prednisolone—ulcerative colitis	6.61e-05	0.000833	CcSEcCtD
Lidocaine—Loss of consciousness—Hydrocortisone—ulcerative colitis	6.57e-05	0.000829	CcSEcCtD
Lidocaine—Bradycardia—Prednisone—ulcerative colitis	6.5e-05	0.00082	CcSEcCtD
Lidocaine—Convulsion—Hydrocortisone—ulcerative colitis	6.48e-05	0.000817	CcSEcCtD
Lidocaine—Hypertension—Hydrocortisone—ulcerative colitis	6.45e-05	0.000814	CcSEcCtD
Lidocaine—Angioedema—Triamcinolone—ulcerative colitis	6.43e-05	0.000811	CcSEcCtD
Lidocaine—Haemoglobin—Prednisone—ulcerative colitis	6.42e-05	0.00081	CcSEcCtD
Lidocaine—Angioedema—Methylprednisolone—ulcerative colitis	6.42e-05	0.000809	CcSEcCtD
Lidocaine—Haemorrhage—Prednisone—ulcerative colitis	6.39e-05	0.000806	CcSEcCtD
Lidocaine—Erythema—Dexamethasone—ulcerative colitis	6.39e-05	0.000805	CcSEcCtD
Lidocaine—Erythema—Betamethasone—ulcerative colitis	6.39e-05	0.000805	CcSEcCtD
Lidocaine—Anxiety—Hydrocortisone—ulcerative colitis	6.34e-05	0.0008	CcSEcCtD
Lidocaine—Hypersensitivity—Mesalazine—ulcerative colitis	6.32e-05	0.000797	CcSEcCtD
Lidocaine—Nausea—Budesonide—ulcerative colitis	6.27e-05	0.00079	CcSEcCtD
Lidocaine—Oedema—Prednisolone—ulcerative colitis	6.25e-05	0.000788	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisolone—ulcerative colitis	6.25e-05	0.000788	CcSEcCtD
Lidocaine—Dizziness—Azathioprine—ulcerative colitis	6.23e-05	0.000785	CcSEcCtD
Lidocaine—Loss of consciousness—Triamcinolone—ulcerative colitis	6.19e-05	0.00078	CcSEcCtD
Lidocaine—Loss of consciousness—Methylprednisolone—ulcerative colitis	6.17e-05	0.000778	CcSEcCtD
Lidocaine—Asthenia—Mesalazine—ulcerative colitis	6.15e-05	0.000776	CcSEcCtD
Lidocaine—Shock—Prednisolone—ulcerative colitis	6.14e-05	0.000775	CcSEcCtD
Lidocaine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	6.1e-05	0.000769	CcSEcCtD
Lidocaine—Oedema—Hydrocortisone—ulcerative colitis	6.1e-05	0.000769	CcSEcCtD
Lidocaine—Convulsion—Triamcinolone—ulcerative colitis	6.1e-05	0.000769	CcSEcCtD
Lidocaine—Convulsion—Methylprednisolone—ulcerative colitis	6.08e-05	0.000767	CcSEcCtD
Lidocaine—Hypertension—Triamcinolone—ulcerative colitis	6.08e-05	0.000766	CcSEcCtD
Lidocaine—Hypertension—Methylprednisolone—ulcerative colitis	6.06e-05	0.000765	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisolone—ulcerative colitis	6.04e-05	0.000762	CcSEcCtD
Lidocaine—Shock—Hydrocortisone—ulcerative colitis	6e-05	0.000757	CcSEcCtD
Lidocaine—Vomiting—Azathioprine—ulcerative colitis	5.99e-05	0.000755	CcSEcCtD
Lidocaine—Nervous system disorder—Hydrocortisone—ulcerative colitis	5.98e-05	0.000755	CcSEcCtD
Lidocaine—Eye disorder—Prednisone—ulcerative colitis	5.97e-05	0.000753	CcSEcCtD
Lidocaine—Anxiety—Methylprednisolone—ulcerative colitis	5.96e-05	0.000751	CcSEcCtD
Lidocaine—Rash—Azathioprine—ulcerative colitis	5.94e-05	0.000749	CcSEcCtD
Lidocaine—Dermatitis—Azathioprine—ulcerative colitis	5.93e-05	0.000748	CcSEcCtD
Lidocaine—Flushing—Prednisone—ulcerative colitis	5.93e-05	0.000748	CcSEcCtD
Lidocaine—Headache—Azathioprine—ulcerative colitis	5.9e-05	0.000744	CcSEcCtD
Lidocaine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	5.9e-05	0.000744	CcSEcCtD
Lidocaine—Angioedema—Dexamethasone—ulcerative colitis	5.83e-05	0.000736	CcSEcCtD
Lidocaine—Angioedema—Betamethasone—ulcerative colitis	5.83e-05	0.000736	CcSEcCtD
Lidocaine—Angiopathy—Prednisone—ulcerative colitis	5.8e-05	0.000731	CcSEcCtD
Lidocaine—Confusional state—Methylprednisolone—ulcerative colitis	5.78e-05	0.000729	CcSEcCtD
Lidocaine—Immune system disorder—Prednisone—ulcerative colitis	5.77e-05	0.000728	CcSEcCtD
Lidocaine—Oedema—Triamcinolone—ulcerative colitis	5.74e-05	0.000724	CcSEcCtD
Lidocaine—Anaphylactic shock—Triamcinolone—ulcerative colitis	5.74e-05	0.000724	CcSEcCtD
Lidocaine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	5.73e-05	0.000723	CcSEcCtD
Lidocaine—Hypotension—Hydrocortisone—ulcerative colitis	5.7e-05	0.000719	CcSEcCtD
Lidocaine—Dizziness—Mesalazine—ulcerative colitis	5.67e-05	0.000715	CcSEcCtD
Lidocaine—Shock—Triamcinolone—ulcerative colitis	5.65e-05	0.000713	CcSEcCtD
Lidocaine—Shock—Methylprednisolone—ulcerative colitis	5.64e-05	0.000711	CcSEcCtD
Lidocaine—Nervous system disorder—Methylprednisolone—ulcerative colitis	5.62e-05	0.000709	CcSEcCtD
Lidocaine—Loss of consciousness—Dexamethasone—ulcerative colitis	5.61e-05	0.000708	CcSEcCtD
Lidocaine—Loss of consciousness—Betamethasone—ulcerative colitis	5.61e-05	0.000708	CcSEcCtD
Lidocaine—Paraesthesia—Prednisolone—ulcerative colitis	5.61e-05	0.000707	CcSEcCtD
Lidocaine—Nausea—Azathioprine—ulcerative colitis	5.59e-05	0.000706	CcSEcCtD
Lidocaine—Erythema—Prednisone—ulcerative colitis	5.56e-05	0.000701	CcSEcCtD
Lidocaine—Hyperhidrosis—Triamcinolone—ulcerative colitis	5.55e-05	0.0007	CcSEcCtD
Lidocaine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	5.54e-05	0.000699	CcSEcCtD
Lidocaine—Convulsion—Betamethasone—ulcerative colitis	5.53e-05	0.000698	CcSEcCtD
Lidocaine—Convulsion—Dexamethasone—ulcerative colitis	5.53e-05	0.000698	CcSEcCtD
Lidocaine—Hypertension—Dexamethasone—ulcerative colitis	5.51e-05	0.000695	CcSEcCtD
Lidocaine—Hypertension—Betamethasone—ulcerative colitis	5.51e-05	0.000695	CcSEcCtD
Lidocaine—Paraesthesia—Hydrocortisone—ulcerative colitis	5.48e-05	0.000691	CcSEcCtD
Lidocaine—Vomiting—Mesalazine—ulcerative colitis	5.45e-05	0.000688	CcSEcCtD
Lidocaine—Anxiety—Betamethasone—ulcerative colitis	5.42e-05	0.000683	CcSEcCtD
Lidocaine—Anxiety—Dexamethasone—ulcerative colitis	5.42e-05	0.000683	CcSEcCtD
Lidocaine—Rash—Mesalazine—ulcerative colitis	5.41e-05	0.000682	CcSEcCtD
Lidocaine—Dermatitis—Mesalazine—ulcerative colitis	5.4e-05	0.000682	CcSEcCtD
Lidocaine—Headache—Mesalazine—ulcerative colitis	5.37e-05	0.000678	CcSEcCtD
Lidocaine—Hypotension—Methylprednisolone—ulcerative colitis	5.36e-05	0.000675	CcSEcCtD
Lidocaine—Pain—Prednisolone—ulcerative colitis	5.34e-05	0.000674	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	5.27e-05	0.000664	CcSEcCtD
Lidocaine—Vision blurred—Prednisone—ulcerative colitis	5.24e-05	0.000661	CcSEcCtD
Lidocaine—Pain—Hydrocortisone—ulcerative colitis	5.22e-05	0.000658	CcSEcCtD
Lidocaine—Oedema—Betamethasone—ulcerative colitis	5.21e-05	0.000657	CcSEcCtD
Lidocaine—Oedema—Dexamethasone—ulcerative colitis	5.21e-05	0.000657	CcSEcCtD
Lidocaine—Anaphylactic shock—Betamethasone—ulcerative colitis	5.21e-05	0.000657	CcSEcCtD
Lidocaine—Anaphylactic shock—Dexamethasone—ulcerative colitis	5.21e-05	0.000657	CcSEcCtD
Lidocaine—Paraesthesia—Triamcinolone—ulcerative colitis	5.16e-05	0.000651	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisolone—ulcerative colitis	5.15e-05	0.000649	CcSEcCtD
Lidocaine—Paraesthesia—Methylprednisolone—ulcerative colitis	5.15e-05	0.000649	CcSEcCtD
Lidocaine—Shock—Dexamethasone—ulcerative colitis	5.13e-05	0.000647	CcSEcCtD
Lidocaine—Shock—Betamethasone—ulcerative colitis	5.13e-05	0.000647	CcSEcCtD
Lidocaine—Dyspnoea—Triamcinolone—ulcerative colitis	5.12e-05	0.000646	CcSEcCtD
Lidocaine—Nervous system disorder—Dexamethasone—ulcerative colitis	5.11e-05	0.000645	CcSEcCtD
Lidocaine—Nervous system disorder—Betamethasone—ulcerative colitis	5.11e-05	0.000645	CcSEcCtD
Lidocaine—Agitation—Prednisone—ulcerative colitis	5.11e-05	0.000645	CcSEcCtD
Lidocaine—Nausea—Mesalazine—ulcerative colitis	5.1e-05	0.000643	CcSEcCtD
Lidocaine—Angioedema—Prednisone—ulcerative colitis	5.08e-05	0.000641	CcSEcCtD
Lidocaine—Hyperhidrosis—Betamethasone—ulcerative colitis	5.04e-05	0.000635	CcSEcCtD
Lidocaine—Hyperhidrosis—Dexamethasone—ulcerative colitis	5.04e-05	0.000635	CcSEcCtD
Lidocaine—Feeling abnormal—Hydrocortisone—ulcerative colitis	5.03e-05	0.000634	CcSEcCtD
Lidocaine—Urticaria—Prednisolone—ulcerative colitis	4.96e-05	0.000626	CcSEcCtD
Lidocaine—Pain—Triamcinolone—ulcerative colitis	4.91e-05	0.00062	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—ulcerative colitis	4.89e-05	0.000616	CcSEcCtD
Lidocaine—Hypotension—Dexamethasone—ulcerative colitis	4.87e-05	0.000614	CcSEcCtD
Lidocaine—Hypotension—Betamethasone—ulcerative colitis	4.87e-05	0.000614	CcSEcCtD
Lidocaine—Urticaria—Hydrocortisone—ulcerative colitis	4.85e-05	0.000611	CcSEcCtD
Lidocaine—Convulsion—Prednisone—ulcerative colitis	4.82e-05	0.000608	CcSEcCtD
Lidocaine—Hypertension—Prednisone—ulcerative colitis	4.8e-05	0.000606	CcSEcCtD
Lidocaine—Feeling abnormal—Triamcinolone—ulcerative colitis	4.73e-05	0.000597	CcSEcCtD
Lidocaine—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.72e-05	0.000596	CcSEcCtD
Lidocaine—Anxiety—Prednisone—ulcerative colitis	4.72e-05	0.000595	CcSEcCtD
Lidocaine—Paraesthesia—Betamethasone—ulcerative colitis	4.68e-05	0.00059	CcSEcCtD
Lidocaine—Paraesthesia—Dexamethasone—ulcerative colitis	4.68e-05	0.00059	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisolone—ulcerative colitis	4.6e-05	0.00058	CcSEcCtD
Lidocaine—Urticaria—Triamcinolone—ulcerative colitis	4.56e-05	0.000576	CcSEcCtD
Lidocaine—Urticaria—Methylprednisolone—ulcerative colitis	4.55e-05	0.000574	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—ulcerative colitis	4.54e-05	0.000572	CcSEcCtD
Lidocaine—Oedema—Prednisone—ulcerative colitis	4.54e-05	0.000572	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	4.5e-05	0.000568	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	4.5e-05	0.000568	CcSEcCtD
Lidocaine—Hypersensitivity—Hydrocortisone—ulcerative colitis	4.49e-05	0.000567	CcSEcCtD
Lidocaine—Shock—Prednisone—ulcerative colitis	4.47e-05	0.000563	CcSEcCtD
Lidocaine—Pain—Dexamethasone—ulcerative colitis	4.46e-05	0.000562	CcSEcCtD
Lidocaine—Pain—Betamethasone—ulcerative colitis	4.46e-05	0.000562	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—ulcerative colitis	4.45e-05	0.000561	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—ulcerative colitis	4.39e-05	0.000553	CcSEcCtD
Lidocaine—Asthenia—Hydrocortisone—ulcerative colitis	4.38e-05	0.000552	CcSEcCtD
Lidocaine—Feeling abnormal—Dexamethasone—ulcerative colitis	4.29e-05	0.000542	CcSEcCtD
Lidocaine—Feeling abnormal—Betamethasone—ulcerative colitis	4.29e-05	0.000542	CcSEcCtD
Lidocaine—Hypersensitivity—Triamcinolone—ulcerative colitis	4.23e-05	0.000534	CcSEcCtD
Lidocaine—Hypersensitivity—Methylprednisolone—ulcerative colitis	4.22e-05	0.000533	CcSEcCtD
Lidocaine—Urticaria—Betamethasone—ulcerative colitis	4.14e-05	0.000522	CcSEcCtD
Lidocaine—Urticaria—Dexamethasone—ulcerative colitis	4.14e-05	0.000522	CcSEcCtD
Lidocaine—Dizziness—Prednisolone—ulcerative colitis	4.13e-05	0.000521	CcSEcCtD
Lidocaine—Asthenia—Triamcinolone—ulcerative colitis	4.12e-05	0.00052	CcSEcCtD
Lidocaine—Asthenia—Methylprednisolone—ulcerative colitis	4.11e-05	0.000519	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—ulcerative colitis	4.08e-05	0.000514	CcSEcCtD
Lidocaine—Dizziness—Hydrocortisone—ulcerative colitis	4.03e-05	0.000509	CcSEcCtD
Lidocaine—Rash—Prednisolone—ulcerative colitis	3.94e-05	0.000497	CcSEcCtD
Lidocaine—Dermatitis—Prednisolone—ulcerative colitis	3.93e-05	0.000496	CcSEcCtD
Lidocaine—Headache—Prednisolone—ulcerative colitis	3.91e-05	0.000494	CcSEcCtD
Lidocaine—Vomiting—Hydrocortisone—ulcerative colitis	3.88e-05	0.000489	CcSEcCtD
Lidocaine—Rash—Hydrocortisone—ulcerative colitis	3.85e-05	0.000485	CcSEcCtD
Lidocaine—Dermatitis—Hydrocortisone—ulcerative colitis	3.84e-05	0.000485	CcSEcCtD
Lidocaine—Headache—Hydrocortisone—ulcerative colitis	3.82e-05	0.000482	CcSEcCtD
Lidocaine—Dizziness—Triamcinolone—ulcerative colitis	3.8e-05	0.000479	CcSEcCtD
Lidocaine—Dizziness—Methylprednisolone—ulcerative colitis	3.79e-05	0.000478	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—ulcerative colitis	3.74e-05	0.000472	CcSEcCtD
Lidocaine—Asthenia—Dexamethasone—ulcerative colitis	3.74e-05	0.000472	CcSEcCtD
Lidocaine—Asthenia—Betamethasone—ulcerative colitis	3.74e-05	0.000472	CcSEcCtD
Lidocaine—Nausea—Prednisolone—ulcerative colitis	3.71e-05	0.000468	CcSEcCtD
Lidocaine—Vomiting—Triamcinolone—ulcerative colitis	3.65e-05	0.000461	CcSEcCtD
Lidocaine—Vomiting—Methylprednisolone—ulcerative colitis	3.64e-05	0.00046	CcSEcCtD
Lidocaine—Nausea—Hydrocortisone—ulcerative colitis	3.62e-05	0.000457	CcSEcCtD
Lidocaine—Rash—Triamcinolone—ulcerative colitis	3.62e-05	0.000457	CcSEcCtD
Lidocaine—Dermatitis—Triamcinolone—ulcerative colitis	3.62e-05	0.000456	CcSEcCtD
Lidocaine—Rash—Methylprednisolone—ulcerative colitis	3.61e-05	0.000456	CcSEcCtD
Lidocaine—Dermatitis—Methylprednisolone—ulcerative colitis	3.61e-05	0.000455	CcSEcCtD
Lidocaine—Urticaria—Prednisone—ulcerative colitis	3.61e-05	0.000455	CcSEcCtD
Lidocaine—Headache—Triamcinolone—ulcerative colitis	3.6e-05	0.000454	CcSEcCtD
Lidocaine—Headache—Methylprednisolone—ulcerative colitis	3.59e-05	0.000453	CcSEcCtD
Lidocaine—Dizziness—Dexamethasone—ulcerative colitis	3.45e-05	0.000435	CcSEcCtD
Lidocaine—Dizziness—Betamethasone—ulcerative colitis	3.45e-05	0.000435	CcSEcCtD
Lidocaine—Nausea—Triamcinolone—ulcerative colitis	3.41e-05	0.00043	CcSEcCtD
Lidocaine—Nausea—Methylprednisolone—ulcerative colitis	3.4e-05	0.000429	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—ulcerative colitis	3.34e-05	0.000422	CcSEcCtD
Lidocaine—Vomiting—Betamethasone—ulcerative colitis	3.31e-05	0.000418	CcSEcCtD
Lidocaine—Vomiting—Dexamethasone—ulcerative colitis	3.31e-05	0.000418	CcSEcCtD
Lidocaine—Rash—Betamethasone—ulcerative colitis	3.29e-05	0.000414	CcSEcCtD
Lidocaine—Rash—Dexamethasone—ulcerative colitis	3.29e-05	0.000414	CcSEcCtD
Lidocaine—Dermatitis—Dexamethasone—ulcerative colitis	3.28e-05	0.000414	CcSEcCtD
Lidocaine—Dermatitis—Betamethasone—ulcerative colitis	3.28e-05	0.000414	CcSEcCtD
Lidocaine—Headache—Dexamethasone—ulcerative colitis	3.26e-05	0.000412	CcSEcCtD
Lidocaine—Headache—Betamethasone—ulcerative colitis	3.26e-05	0.000412	CcSEcCtD
Lidocaine—Asthenia—Prednisone—ulcerative colitis	3.26e-05	0.000411	CcSEcCtD
Lidocaine—Nausea—Dexamethasone—ulcerative colitis	3.1e-05	0.00039	CcSEcCtD
Lidocaine—Nausea—Betamethasone—ulcerative colitis	3.1e-05	0.00039	CcSEcCtD
Lidocaine—Dizziness—Prednisone—ulcerative colitis	3e-05	0.000379	CcSEcCtD
Lidocaine—Vomiting—Prednisone—ulcerative colitis	2.89e-05	0.000364	CcSEcCtD
Lidocaine—Rash—Prednisone—ulcerative colitis	2.86e-05	0.000361	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—ulcerative colitis	2.86e-05	0.000361	CcSEcCtD
Lidocaine—Headache—Prednisone—ulcerative colitis	2.84e-05	0.000359	CcSEcCtD
Lidocaine—Nausea—Prednisone—ulcerative colitis	2.7e-05	0.00034	CcSEcCtD
Lidocaine—EGFR—Signaling by NGF—RELA—ulcerative colitis	1.23e-05	0.000466	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—TNF—ulcerative colitis	1.22e-05	0.000462	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	1.22e-05	0.000462	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—RELA—ulcerative colitis	1.21e-05	0.000459	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TGFB1—ulcerative colitis	1.21e-05	0.000459	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	1.21e-05	0.000459	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IRF8—ulcerative colitis	1.19e-05	0.000452	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CCR6—ulcerative colitis	1.19e-05	0.000452	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.19e-05	0.000452	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	1.18e-05	0.000449	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TNF—ulcerative colitis	1.17e-05	0.000444	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TNF—ulcerative colitis	1.17e-05	0.000444	CbGpPWpGaD
Lidocaine—EGFR—Disease—SLC11A1—ulcerative colitis	1.16e-05	0.00044	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ADCY5—ulcerative colitis	1.16e-05	0.00044	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PTGER4—ulcerative colitis	1.15e-05	0.000436	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—JAK2—ulcerative colitis	1.15e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—IL6—ulcerative colitis	1.14e-05	0.000434	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FCGR2A—ulcerative colitis	1.14e-05	0.000431	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TNF—ulcerative colitis	1.14e-05	0.000431	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—DLD—ulcerative colitis	1.13e-05	0.000429	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TNF—ulcerative colitis	1.13e-05	0.000428	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS1—ulcerative colitis	1.11e-05	0.000422	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.11e-05	0.000422	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.11e-05	0.000421	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—DLD—ulcerative colitis	1.1e-05	0.000419	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.1e-05	0.000416	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	1.09e-05	0.000415	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTPN2—ulcerative colitis	1.09e-05	0.000414	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—ulcerative colitis	1.09e-05	0.000412	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—IL6—ulcerative colitis	1.08e-05	0.000409	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GHRL—ulcerative colitis	1.05e-05	0.000399	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.05e-05	0.000398	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCR1—ulcerative colitis	1.05e-05	0.000397	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAML2—ulcerative colitis	1.04e-05	0.000396	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.04e-05	0.000394	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—NFKB1—ulcerative colitis	1.03e-05	0.000393	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MMP9—ulcerative colitis	1.03e-05	0.000391	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—IL6—ulcerative colitis	1.03e-05	0.00039	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—IL6—ulcerative colitis	1.03e-05	0.00039	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—IL6—ulcerative colitis	1.02e-05	0.000388	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NFKB1—ulcerative colitis	1.02e-05	0.000387	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CALM3—ulcerative colitis	1.02e-05	0.000386	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—IL6—ulcerative colitis	1.02e-05	0.000386	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CRP—ulcerative colitis	1.01e-05	0.000385	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—IL6—ulcerative colitis	1.01e-05	0.000385	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CALM3—ulcerative colitis	1e-05	0.00038	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—IL6—ulcerative colitis	9.83e-06	0.000373	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	9.79e-06	0.000372	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—PPARG—ulcerative colitis	9.78e-06	0.000371	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—TLR4—ulcerative colitis	9.71e-06	0.000369	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CHP1—ulcerative colitis	9.66e-06	0.000367	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—DLD—ulcerative colitis	9.57e-06	0.000363	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—IL6—ulcerative colitis	9.53e-06	0.000362	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—IL6—ulcerative colitis	9.53e-06	0.000362	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	9.53e-06	0.000362	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP9—ulcerative colitis	9.46e-06	0.000359	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—IL6—ulcerative colitis	9.44e-06	0.000359	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—IL6—ulcerative colitis	9.44e-06	0.000359	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—IL6—ulcerative colitis	9.44e-06	0.000359	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	9.36e-06	0.000355	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	9.32e-06	0.000354	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—IL6—ulcerative colitis	9.32e-06	0.000354	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CALM3—ulcerative colitis	9.3e-06	0.000353	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—STAT3—ulcerative colitis	9.29e-06	0.000353	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL20—ulcerative colitis	9.19e-06	0.000349	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—STAT3—ulcerative colitis	9.16e-06	0.000348	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RIPK2—ulcerative colitis	9.16e-06	0.000348	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—IL6—ulcerative colitis	9.11e-06	0.000346	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CHP1—ulcerative colitis	9.1e-06	0.000346	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTLA4—ulcerative colitis	9.03e-06	0.000343	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CHP1—ulcerative colitis	9.02e-06	0.000343	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—IL6—ulcerative colitis	8.97e-06	0.000341	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ICAM1—ulcerative colitis	8.94e-06	0.00034	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—ADRB2—ulcerative colitis	8.7e-06	0.00033	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNA12—ulcerative colitis	8.64e-06	0.000328	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD79A—ulcerative colitis	8.61e-06	0.000327	CbGpPWpGaD
Lidocaine—EGFR—Disease—CALM3—ulcerative colitis	8.58e-06	0.000326	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—ulcerative colitis	8.49e-06	0.000323	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.45e-06	0.000321	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	8.44e-06	0.00032	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—DLD—ulcerative colitis	8.34e-06	0.000317	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	8.3e-06	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NOD2—ulcerative colitis	8.3e-06	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD14—ulcerative colitis	8.26e-06	0.000313	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCR2—ulcerative colitis	8.19e-06	0.000311	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—JAK2—ulcerative colitis	8.17e-06	0.00031	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	8.15e-06	0.00031	CbGpPWpGaD
Lidocaine—EGFR—Immune System—VCAM1—ulcerative colitis	7.97e-06	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DQA1—ulcerative colitis	7.95e-06	0.000302	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TNF—ulcerative colitis	7.93e-06	0.000301	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—RELA—ulcerative colitis	7.92e-06	0.000301	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDH1—ulcerative colitis	7.91e-06	0.0003	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—DLD—ulcerative colitis	7.86e-06	0.000298	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—DLD—ulcerative colitis	7.79e-06	0.000296	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ABCB1—ulcerative colitis	7.78e-06	0.000295	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CHP1—ulcerative colitis	7.71e-06	0.000293	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCR6—ulcerative colitis	7.7e-06	0.000292	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS1—ulcerative colitis	7.39e-06	0.000281	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—ADCY5—ulcerative colitis	7.38e-06	0.00028	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAML2—ulcerative colitis	7.3e-06	0.000277	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ADCY5—ulcerative colitis	7.26e-06	0.000276	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.22e-06	0.000274	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—JAK2—ulcerative colitis	7.22e-06	0.000274	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	7.21e-06	0.000274	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—RELA—ulcerative colitis	6.99e-06	0.000266	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CD4—ulcerative colitis	6.84e-06	0.00026	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTGER4—ulcerative colitis	6.78e-06	0.000257	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS1—ulcerative colitis	6.77e-06	0.000257	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP9—ulcerative colitis	6.75e-06	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ADCY5—ulcerative colitis	6.74e-06	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—RELA—ulcerative colitis	6.71e-06	0.000255	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NFKB1—ulcerative colitis	6.68e-06	0.000254	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—DLD—ulcerative colitis	6.65e-06	0.000253	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CALM3—ulcerative colitis	6.65e-06	0.000253	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD4—ulcerative colitis	6.57e-06	0.00025	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—IL6—ulcerative colitis	6.49e-06	0.000246	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—IL6—ulcerative colitis	6.4e-06	0.000243	CbGpPWpGaD
Lidocaine—EGFR—Disease—ADCY5—ulcerative colitis	6.23e-06	0.000236	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GHRL—ulcerative colitis	6.21e-06	0.000236	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CALM3—ulcerative colitis	6.1e-06	0.000232	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CALM3—ulcerative colitis	6.01e-06	0.000228	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	6e-06	0.000228	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—STAT3—ulcerative colitis	6e-06	0.000228	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CHP1—ulcerative colitis	5.95e-06	0.000226	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RIPK2—ulcerative colitis	5.92e-06	0.000225	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CRP—ulcerative colitis	5.9e-06	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NFKB1—ulcerative colitis	5.9e-06	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—IL6—ulcerative colitis	5.87e-06	0.000223	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NFKB1—ulcerative colitis	5.66e-06	0.000215	CbGpPWpGaD
Lidocaine—EGFR—Immune System—TLR4—ulcerative colitis	5.66e-06	0.000215	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DRB1—ulcerative colitis	5.65e-06	0.000215	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	5.62e-06	0.000213	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	5.61e-06	0.000213	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—ulcerative colitis	5.56e-06	0.000211	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS1—ulcerative colitis	5.46e-06	0.000207	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ICAM1—ulcerative colitis	5.42e-06	0.000206	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PPARG—ulcerative colitis	5.41e-06	0.000206	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS1—ulcerative colitis	5.34e-06	0.000203	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TNF—ulcerative colitis	5.19e-06	0.000197	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ABCB1—ulcerative colitis	5.17e-06	0.000196	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ADRB2—ulcerative colitis	5.14e-06	0.000195	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—DLD—ulcerative colitis	5.14e-06	0.000195	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.06e-06	0.000192	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.94e-06	0.000188	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CALM3—ulcerative colitis	4.92e-06	0.000187	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ALB—ulcerative colitis	4.87e-06	0.000185	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ADCY5—ulcerative colitis	4.83e-06	0.000183	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CALM3—ulcerative colitis	4.81e-06	0.000183	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDH1—ulcerative colitis	4.8e-06	0.000182	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ABCB1—ulcerative colitis	4.74e-06	0.00018	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS1—ulcerative colitis	4.63e-06	0.000176	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—JAK2—ulcerative colitis	4.6e-06	0.000175	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.55e-06	0.000173	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ADCY5—ulcerative colitis	4.42e-06	0.000168	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ADCY5—ulcerative colitis	4.36e-06	0.000166	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—ulcerative colitis	4.26e-06	0.000162	CbGpPWpGaD
Lidocaine—EGFR—Immune System—JAK2—ulcerative colitis	4.21e-06	0.00016	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CXCL8—ulcerative colitis	4.2e-06	0.000159	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—IL6—ulcerative colitis	4.19e-06	0.000159	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CALM3—ulcerative colitis	4.16e-06	0.000158	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IFNG—ulcerative colitis	4.13e-06	0.000157	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.12e-06	0.000156	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RELA—ulcerative colitis	4.07e-06	0.000155	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS1—ulcerative colitis	4.03e-06	0.000153	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2—ulcerative colitis	4.01e-06	0.000152	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD4—ulcerative colitis	3.99e-06	0.000151	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.98e-06	0.000151	CbGpPWpGaD
Lidocaine—EGFR—Disease—JAK2—ulcerative colitis	3.88e-06	0.000147	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ABCB1—ulcerative colitis	3.83e-06	0.000145	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	3.8e-06	0.000144	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.77e-06	0.000143	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.76e-06	0.000143	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ABCB1—ulcerative colitis	3.74e-06	0.000142	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.7e-06	0.000141	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IL6—ulcerative colitis	3.7e-06	0.000141	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL1B—ulcerative colitis	3.68e-06	0.00014	CbGpPWpGaD
Lidocaine—EGFR—Disease—CD4—ulcerative colitis	3.68e-06	0.00014	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2—ulcerative colitis	3.67e-06	0.000139	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—ulcerative colitis	3.65e-06	0.000139	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CALM3—ulcerative colitis	3.63e-06	0.000138	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PPARG—ulcerative colitis	3.6e-06	0.000137	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ADCY5—ulcerative colitis	3.57e-06	0.000136	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.52e-06	0.000134	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ADCY5—ulcerative colitis	3.49e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NFKB1—ulcerative colitis	3.43e-06	0.00013	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.42e-06	0.00013	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.39e-06	0.000129	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PPARG—ulcerative colitis	3.3e-06	0.000125	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.24e-06	0.000123	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—ulcerative colitis	3.24e-06	0.000123	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—ulcerative colitis	3.24e-06	0.000123	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	3.22e-06	0.000122	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.16e-06	0.00012	CbGpPWpGaD
Lidocaine—EGFR—Immune System—STAT3—ulcerative colitis	3.09e-06	0.000117	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ADCY5—ulcerative colitis	3.02e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—ulcerative colitis	2.97e-06	0.000113	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CALM3—ulcerative colitis	2.9e-06	0.00011	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—ulcerative colitis	2.85e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—ulcerative colitis	2.83e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.77e-06	0.000105	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JAK2—ulcerative colitis	2.72e-06	0.000103	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PPARG—ulcerative colitis	2.66e-06	0.000101	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	2.66e-06	0.000101	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—ulcerative colitis	2.64e-06	0.0001	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.64e-06	0.0001	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RELA—ulcerative colitis	2.63e-06	0.0001	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ADCY5—ulcerative colitis	2.63e-06	0.0001	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPARG—ulcerative colitis	2.6e-06	9.88e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—ulcerative colitis	2.6e-06	9.85e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.48e-06	9.43e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL8—ulcerative colitis	2.48e-06	9.42e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.48e-06	9.42e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.46e-06	9.34e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—ulcerative colitis	2.39e-06	9.09e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—ulcerative colitis	2.37e-06	9e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—ulcerative colitis	2.36e-06	8.96e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—ulcerative colitis	2.34e-06	8.88e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARG—ulcerative colitis	2.25e-06	8.56e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.25e-06	8.55e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—ulcerative colitis	2.24e-06	8.52e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.24e-06	8.49e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NFKB1—ulcerative colitis	2.22e-06	8.43e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—ulcerative colitis	2.16e-06	8.19e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.1e-06	7.98e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—ulcerative colitis	2.09e-06	7.95e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—ulcerative colitis	2.05e-06	7.77e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—ulcerative colitis	2.03e-06	7.69e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—ulcerative colitis	2e-06	7.58e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—ulcerative colitis	1.99e-06	7.56e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARG—ulcerative colitis	1.96e-06	7.45e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARG—ulcerative colitis	1.85e-06	7.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—ulcerative colitis	1.85e-06	7.02e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.83e-06	6.96e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—ulcerative colitis	1.77e-06	6.73e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—ulcerative colitis	1.77e-06	6.7e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.74e-06	6.6e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—ulcerative colitis	1.66e-06	6.32e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—ulcerative colitis	1.65e-06	6.26e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.62e-06	6.16e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.57e-06	5.95e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.54e-06	5.86e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—ulcerative colitis	1.52e-06	5.78e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.46e-06	5.53e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.44e-06	5.48e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—ulcerative colitis	1.41e-06	5.35e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—ulcerative colitis	1.39e-06	5.29e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.23e-06	4.68e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.21e-06	4.59e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—ulcerative colitis	1.09e-06	4.13e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	9.51e-07	3.61e-05	CbGpPWpGaD
